Clinical Trial Update: Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating carboplatin, paclitaxel, and cetuximab for recurrent/metastatic head and neck squamous cell carcinoma after failure of pembr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cetuximab (cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Centre Paul Strauss | Conditions: Head and Neck Cancer | Phase 2 | Status: RECRUITING